Skip to main content
Top
Published in: Acta Diabetologica 1/2019

01-01-2019 | Original Article

Efficacy of urinary glucose for diabetes screening: a reconsideration

Authors: Juan Chen, Haijian Guo, Suixia Yuan, Chen Qu, Tao Mao, Shanhu Qiu, Wei Li, Xiaohang Wang, Min Cai, Hong Sun, Bei Wang, Xiaoning Li, Zilin Sun

Published in: Acta Diabetologica | Issue 1/2019

Login to get access

Abstract

Aims

Previous studies indicated that urinary glucose (UG) had a limited efficacy in diabetes screening. This study was designed to have a re-evaluation of its efficacy, taking into consideration the collection method of urine and the measurement approach for UG among Chinese adults.

Methods

This cross-sectional study enrolled a total of 7689 participants without known diabetes, who were fasted and asked to empty bladders before a 75 g glucose loading. Urine was collected 2 h post glucose loading, and UG was measured using quantitative and qualitative approaches. The efficacy of UG in detecting diabetes was assessed by the receiver operating characteristic (ROC) curve.

Results

The area under the ROC curve was 0.89 for quantitative UG and 0.87 for qualitative UG. Quantitative UG was positively correlated with fasting plasma glucose (FPG) and 2 h plasma glucose (2 h PG) (r = 0.55 and 0.56, respectively, both P < 0.001). Quantitative UG displayed a sensitivity of 82.9% and a specificity of 84.7% in detecting diabetes at the corresponding optimal cutoff of 130 mg. Qualitative UG exhibited a sensitivity of 80.2% and a specificity of 85.6% at the optimal cutoff of glycosuria + 1. In addition, the sensitivity of both quantitative and qualitative UG was significantly higher than that of HbA1c (≥ 6.5%) (P < 0.001) and had a comparable sensitivity to 2 h PG (≥ 11.1 mmol/L) (P = 0.493).

Conclusions

UG, either quantitatively or qualitatively measured at 2 h post glucose loading, was effective in diabetes screening. This indicates that UG is a feasible approach for diabetes screening.
Literature
7.
go back to reference Wang W, Lee ET, Fabsitz R, Welty TK, Howard BV (2002) Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study. Diabetes Care 25:1365–1370CrossRefPubMed Wang W, Lee ET, Fabsitz R, Welty TK, Howard BV (2002) Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study. Diabetes Care 25:1365–1370CrossRefPubMed
8.
go back to reference Deepa R, Shanthi RS, Premalatha G, Mohan V (2000) Comparison of ADA 1997 and WHO 1985 criteria for diabetes in south Indians—the Chennai Urban Population Study. American Diabetes Association. Diabet Med 17:872–874CrossRefPubMed Deepa R, Shanthi RS, Premalatha G, Mohan V (2000) Comparison of ADA 1997 and WHO 1985 criteria for diabetes in south Indians—the Chennai Urban Population Study. American Diabetes Association. Diabet Med 17:872–874CrossRefPubMed
10.
go back to reference Li-nong J, Wei L, Wei L et al (2010) Impact of newly recommended HbA1c-based diabetes diagnostic criteria on the prevalence of diabetes and high risk individual in clinical and community population in China. Chin Med J (Engl) 123:1103–1104 Li-nong J, Wei L, Wei L et al (2010) Impact of newly recommended HbA1c-based diabetes diagnostic criteria on the prevalence of diabetes and high risk individual in clinical and community population in China. Chin Med J (Engl) 123:1103–1104
13.
go back to reference Davies MJ, Williams DR, Metcalfe J, Day JL (1993) Community screening for non-insulin-dependent diabetes mellitus: self-testing for post-prandial glycosuria. Q J Med 86:677–684CrossRefPubMed Davies MJ, Williams DR, Metcalfe J, Day JL (1993) Community screening for non-insulin-dependent diabetes mellitus: self-testing for post-prandial glycosuria. Q J Med 86:677–684CrossRefPubMed
14.
go back to reference Hanson RL, Nelson RG, McCance DR et al (1993) Comparison of screening tests for non-insulin-dependent diabetes mellitus. Arch Intern Med 153:2133–2140CrossRefPubMed Hanson RL, Nelson RG, McCance DR et al (1993) Comparison of screening tests for non-insulin-dependent diabetes mellitus. Arch Intern Med 153:2133–2140CrossRefPubMed
15.
go back to reference Friderichsen B, Maunsbach M (1997) Glycosuric tests should not be employed in population screenings for NIDDM. J Public Health Med 19:55–60CrossRefPubMed Friderichsen B, Maunsbach M (1997) Glycosuric tests should not be employed in population screenings for NIDDM. J Public Health Med 19:55–60CrossRefPubMed
17.
go back to reference Ruhnau B, Faber OK, Borch-Johnsen K, Thorsteinsson B (1997) Renal threshold for glucose in non-insulin-dependent diabetic patients. Diabetes Res Clin Pract 36:27–33CrossRefPubMed Ruhnau B, Faber OK, Borch-Johnsen K, Thorsteinsson B (1997) Renal threshold for glucose in non-insulin-dependent diabetic patients. Diabetes Res Clin Pract 36:27–33CrossRefPubMed
20.
go back to reference Urakami T, Kubota S, Nitadori Y et al (2005) Annual incidence and clinical characteristics of type 2 diabetes in children as detected by urine glucose screening in the Tokyo metropolitan area. Diabetes Care 28:1876–1881CrossRefPubMed Urakami T, Kubota S, Nitadori Y et al (2005) Annual incidence and clinical characteristics of type 2 diabetes in children as detected by urine glucose screening in the Tokyo metropolitan area. Diabetes Care 28:1876–1881CrossRefPubMed
26.
go back to reference Bao Y, Ma X, Li H et al (2010) Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. BMJ 340:c2249CrossRefPubMedPubMedCentral Bao Y, Ma X, Li H et al (2010) Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. BMJ 340:c2249CrossRefPubMedPubMedCentral
29.
33.
go back to reference Stride A, Ellard S, Clark P et al (2005) Beta-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1alpha mutation carriers. Diabetes Care 28:1751–1756CrossRefPubMed Stride A, Ellard S, Clark P et al (2005) Beta-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1alpha mutation carriers. Diabetes Care 28:1751–1756CrossRefPubMed
35.
go back to reference Nagai K, Yoshida S, Konishi H (2014) Gender differences in the gene expression profiles of glucose transporter GLUT class I and SGLT in mouse tissues. Pharmazie 69:856–859PubMed Nagai K, Yoshida S, Konishi H (2014) Gender differences in the gene expression profiles of glucose transporter GLUT class I and SGLT in mouse tissues. Pharmazie 69:856–859PubMed
Metadata
Title
Efficacy of urinary glucose for diabetes screening: a reconsideration
Authors
Juan Chen
Haijian Guo
Suixia Yuan
Chen Qu
Tao Mao
Shanhu Qiu
Wei Li
Xiaohang Wang
Min Cai
Hong Sun
Bei Wang
Xiaoning Li
Zilin Sun
Publication date
01-01-2019
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 1/2019
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-018-1212-1

Other articles of this Issue 1/2019

Acta Diabetologica 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.